GSA CAPITAL PARTNERS LLP

Position in TNYA — Tenaya Therapeutics, Inc.

CIK 1362033 LONDON, X0

Position in TNYA

as of Mar 31, 2026 · filed May 8, 2026 Compact

Position Value

$742,454

-$310,317 QoQ

Shares Held

1,072,911

-27.4% QoQ

Ownership

0.494%

of shares outstanding

% of Portfolio

0.05%

of 13F equity value

Holder Rank

#14

of 103 holders

Holding Since

Sep 2022

11 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

GSA CAPITAL PARTNERS LLP holds $99,952,720 across 160 Biotechnology names. TNYA ranks #48 (0.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc.	3,831	$2,959,983
2	ARDX	Ardelyx, Inc.	473,061	$2,833,635
3	NTLA	Intellia Therapeutics, Inc.	178,301	$2,285,818
4	NUVB	Nuvation Bio Inc.	495,792	$2,126,947
5	RXRX	Recursion Pharmaceuticals, Inc.	669,568	$2,055,573
6	WVE	Wave Life Sciences Ltd.	282,719	$2,049,712
7	SRPT	Sarepta Therapeutics, Inc.	90,960	$1,979,289
8	IOVA	Iovance Biotherapeutics, Inc.	557,085	$1,955,368

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$742,454	1,072,911	-27.4%	Shares	Sole	2026-05-08
2025-12-31	$1,052,771	1,478,612	+220.2%	Shares	Sole	2026-02-06
2025-09-30	$748,122	461,804	+212.2%	Shares	Sole	2025-11-07
2024-09-30	$285,508	147,932	-18.7%	Shares	Sole	2024-11-05
2024-06-30	$564,392	182,062	-18.7%	Shares	Sole	2024-08-15
2024-03-31	$1,171,786	224,051	-52.4%	Shares	Sole	2024-05-03
2023-12-31	$1,525,537	470,845	+29.5%	Shares	Sole	2024-02-16
2023-09-30	$926,907	363,493	+194.5%	Shares	Sole	2023-11-15
2023-06-30	$724,422	123,411	+40.0%	Shares	Sole	2023-08-14
2023-03-31	$251,278	88,168	+40.7%	Shares	Sole	2023-05-12
2022-09-30	$181,731	62,666	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.